GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Medicine has always demanded speed, accuracy, and compassion, but physicians in 2025 face greater challenges than ever before ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

Eric Schmidt’s AI predictions reveal a future of innovation, risks, and ethical dilemmas. Are we ready for the rise of ...

D-Wave and Japan Tobacco's pharmaceutical division completed a proof-of-concept project aimed at speeding up and improving the design of ...

This episode of Drug Digest will discuss where the significant bottlenecks are in the development and manufacturing of new ...

Exscientia says it is at the forefront of Artificial Intelligence (AI)-driven drug discovery and design, as it brings together a powerful AI platform with some of the best and most experienced ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...